ChemoMetec A/S (CPH:CHEMM)
Denmark
· Delayed Price · Currency is DKK 599.50
-6.00 (-0.99%)
Feb 21, 2025, 4:59 PM CET
ChemoMetec Revenue
ChemoMetec had revenue of 251.47M DKK in the half year ending December 31, 2024, with 3.63% growth. This brings the company's revenue in the last twelve months to 459.54M, up 14.45% year-over-year. In the fiscal year ending June 30, 2024, ChemoMetec had annual revenue of 407.87M, down -8.22%.
Revenue (ttm)
459.54M
Revenue Growth
+14.45%
P/S Ratio
22.69
Revenue / Employee
2.50M
Employees
174
Market Cap
10.43B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 407.87M | -36.53M | -8.22% |
| Jun 30, 2023 | 444.40M | 16.01M | 3.74% |
| Jun 30, 2022 | 428.39M | 147.26M | 52.38% |
| Jun 30, 2021 | 281.13M | 67.03M | 31.31% |
| Jun 30, 2020 | 214.10M | 38.59M | 21.99% |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
| Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk | 290.40B |
| Coloplast | 27.45B |
| Genmab | 21.53B |
| Demant | 22.42B |
| Zealand Pharma | 62.69M |
| H. Lundbeck | 22.00B |
| Ambu A/S | 5.65B |
| ALK-Abelló | 5.54B |
ChemoMetec News
- 9 days ago - Half Year 2025 Chemometec A/S Earnings Call Transcript - GuruFocus